Compound TPX-0046

CAS No. 2411115-73-4

Compound TPX-0046( —— )

Catalog No. M35979 CAS No. 2411115-73-4

Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 193 Get Quote
5MG 226 Get Quote
10MG 335 Get Quote
25MG 522 Get Quote
50MG 707 Get Quote
100MG 888 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Compound TPX-0046
  • Note
    Research use only, not for human use.
  • Brief Description
    Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.
  • Description
    Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    c-RET
  • Recptor
    c-RET
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2411115-73-4
  • Formula Weight
    424.43
  • Molecular Formula
    C21H21FN6O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H]1CNC(=O)C2=C3N=C4C(=CN3N=C2)O[C@H]5CCC[C@H]5N4CC6=C(O1)N=CC(=C6)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GSK3179106

    GSK3179106 (GSK-3179106, GSK 3179106) is a potent, selective, first-in-class and gut-restricted RET kinase inhibitor with IC50 of 0.4 and 11 nM in the biochemical assay and cellular assay respectively.

  • Enbezotinib

    Enbezotinib is an inhibitor of RET autophosphorylation and can be used in cancer research.

  • Compound TPX-0046

    Compound TPX-0046 is an inhibitor of RET. Compound TPX-0046 can inhibit the RET autophosphorylation. Compound TPX-0046 can be used for the research of cancer.